Through brands in different health fields and life scenarios, we create high-quality healthy life for global consumers, help the upgrading and transformation of global health consumption, and promote the concept innovation and sustainable development of human health

Shandong Henglu Biotechnology Co., Ltd. was founded in March 2018 and is headquartered in Jinan City, Shandong Province. The preparation of human milk oligosaccharides (HMOs) series products by "biological method" is the key transformation direction of scientific and technological achievements, and is committed to the popularization of high value-added raw material products independently developed and produced in the fields of infant formula milk powder, functional food, special medical food, cosmetics and pharmaceuticals application.
Prof. Fang, the founder of Henglu Biology, "Taishan Scholar" and "Taishan Industry Leading Talent", Pro. Fang led the research and development team to innovate the "enzyme/yeast dual method" technology path independently. This process uses carbohydrates as substrates, and applies a new technology pioneered domestically and Successfully synthesized a variety of breast milk oligosaccharides, achieved mass production of multiple HMOs. Henglu is the only one in China to realize the mass production of HMOs has developed a green, energy-saving, high-efficiency, and completely different from Europe and the United States. The technical path has broken through the “bottleneck” technical problem in this field in China.